Circuit Clinical partners to shape data to drive discovery
Circuit Clinical and CUBRC partner to enhance patient data for drug discovery and development services through machine learning platforms and AI.
Archives for May 14, 2019
UPDATED
ACTC selects two drugs for Alzheimer’s for clinical trials
Japanese pharmaceutical company Eisai sends two new Alzheimer’s prevention drugs into the clinic after ACTC selection.
Greenphire partners with Lazarex to ease oncology trial reimbursement
Lazarex partners with Greenphire to implement the latter’s ClinCard reimbursement technology to improve patient participation in oncology trials.
Novartis recalls treatment over peanut contamination risk
Novartis initiates a recall of Promacta after its contract manufacturer introduced peanut flour into the same facility as the treatment, potentially causing cross-contamination.
PE firm invests in growing eClinical solutions company
eClinical technology company, Axiom Real-Time Metrics, will be recapitalized by Great Point Partners to provide eClinical solutions to increase service offerings for Phase I-III clinical trials.
Tension over generic entry sees Gilead donating 2.4m bottles of PrEP
As generic competition looms, Gilead donates 2.4 million bottles of Truvada to the CDC to aid in the center’s fight against the HIV epidemic in the US.
AstraZeneca gets FDA green light for diabetes adjunct treatment
Qternmet XR, an oral adjunct treatment to diet and exercise for patients with type 2 diabetes, gets the approval of the US FDA.